To provide a novel and excellent agent for treating or preventing nociceptive pain, neuropathic pain, cancer pain, headache, bladder function disorder and the like, based on the inhibitory action on the capsaicin receptor VR1 activation.
The present invention was accomplished by confirming that a benzamide derivative characterized by the possession of a benzene ring in which a single ring is condensed on the nitrogen atom of amido group and possession of a lower alkylamino or an amino group substituted with a ring group at the neighboring position of said amido group has a strong inhibitory action on VR1 activation and excellent pharmacological actions based on this and by finding that it can become an excellent agent for treating or preventing VR1-involved diseases such as nociceptive pain, neuropathic pain, cancer pain, headache, bladder function disorder and the like.
Process for the preparation of 3-dihalobenzyl-2,4-quinazolinedione derivatives
申请人:Fuji Chemical Industry Co., Ltd.
公开号:US06201121B1
公开(公告)日:2001-03-13
A process for preparing a 3-dihalobenzyl-2,4-quinazolinedione derivative represented by the formula (V):
(wherein
X1, X2, X3 are independently a halogen atom, and
A is an alkylene group),
which comprises:
reacting a dihalobenzyl derivative represented by the formula (III):
(wherein
X2 and X3 are each as defined above, and
L is an acid residue)
with a 2,4-quinazolinedione derivative having a carboxyalkyl group represented by the formula (I):
(wherein X1 and A are each as defined above)
to selectively substitute a hydrogen atom of an imino group at the 3-position of the derivative (1).
The above process enables the efficient preparation of the compounds of the above formula (V) useful as inhibitors against aldose reductases, makes it possible to secure the safety and hygiene of workers, and can facilitate waste disposal to reduce the expenses, thus being industrially extremely advantageous.
To provide a novel and excellent agent for treating or preventing nociceptive pain, neuropathic pain, cancer pain, headache, bladder function disorder and the like, based on the inhibitory action on the capsaicin receptor VR1 activation.
The present invention was accomplished by confirming that a benzamide derivative characterized by the possession of a benzene ring in which a single ring is condensed on the nitrogen atom of amido group and possession of a lower alkylamino or an amino group substituted with a ring group at the neighboring position of said amido group has a strong inhibitory action on VR1 activation and excellent pharmacological actions based on this and by finding that it can become an excellent agent for treating or preventing VR1-involved diseases such as nociceptive pain, neuropathic pain, cancer pain, headache, bladder function disorder and the like.
PROCESS FOR THE PREPARATION OF 3-DIHALOBENZYL-2,4-QUINAZOLINEDIONE DERIVATIVES
申请人:FUJI CHEMICAL INDUSTRY CO., LTD.
公开号:EP0896961A1
公开(公告)日:1999-02-17
A process for preparing a 3-dihalobenzyl-2,4-quinazolinedione derivative represented by the formula (V):
(wherein
X1, X2, X3 are independently a halogen atom, and
A is an alkylene group),
which comprises:
reacting a dihalobenzyl derivative represented by the formula (III):
(wherein
X2 and X3 are each as defined above, and
L is an acid residue)
with a 2,4-quinazolinedione derivative having a carboxyalkyl group represented by the formula (I):
(wherein
X1 and A are each as defined above)
to selectively substitute a hydrogen atom of an imino group at the 3-position of the derivative (I).
The above process enables the efficient preparation of the compounds of the above formula (V) useful as inhibitors against aldose reductases, makes it possible to secure the safety and hygiene of workers, and can facilitate waste disposal to reduce the expenses, thus being industrially extremely advantageous.